Select Page

FDC (Mid Cap - Next Multibagger) Share Target 2024, 2025 To 2039

FDC Limited

Company Logo Price: ₹491.50
52 Week Low: ₹378.20
52 Week High: ₹658.85
Market Capital: 8,019.98 Crore (Midcap)
Healthcare -> Drug Manufacturers—Specialty & Generic
Show Table of Contents

To predict the FDC's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

FDC Share Price Target For 2024

The line chart displays the monthly closing prices of FDC with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for FDC shares in 2024, see the table below.

FDC Share Price Target Table For 2024

Level Value Analysis
2024 Target 3 510.1 (+3.78%) Price Action: 06 Dec 2024 Low
2024 Target 2 504.6 (+2.66%) Price Action: 14 Nov 2024 High
2024 Target 1 499.45 (+1.61%) Price Action: 16 Dec 2024 Low
Current Price 491.50 FDC's share price as of 20 Dec 2024
Stop Loss 1 487.65 (-0.79%) Fibonacci Retracement Level 98.60%
Stop Loss 2 482.67 (-1.80%) Price Action: Feb 2024 High
Stop Loss 3 475.99 (-3.16%) Fibonacci Retracement Level 28.20%

Short-Term Technical Outlook

Current Technical Position: FDC is displaying bearish momentum trading below key moving averages.

Key Technical Level: The 25-day moving average at ₹505.69 serves as the nearest technical reference point.

Historical Returns: 3-month: -7.96% | 6-month: +7.48% | 1-year: +25.27%

FDC Share Price Target For 2025

The line chart displays the monthly closing prices of FDC with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for FDC shares in 2025, see the table below.

FDC Share Price Target Table For 2025

Level Value Analysis
2025 Target 3 691.38 (+40.66%) Price Action: Chart
2025 Target 2 678.49 (+38.04%) Price Action: Chart
2025 Target 1 671.77 (+36.67%) Fibonacci Extension Level 64.90%
Current Price 491.50 FDC's share price as of 20 Dec 2024
Stop Loss 1 424.53 (-13.63%) Price Action: Aug 2023 High
Stop Loss 2 419.63 (-14.63%) Price Action: Dec 2023 High
Stop Loss 3 412.08 (-16.16%) Price Action: Chart

Long-Term Technical Outlook

52-Week Range Analysis: FDC is currently trading at 40.4% of its 52-week range (₹378.2 - ₹658.85).

Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.

Long-Term Performance: 1-year: +25.27% | 3-year: +63.26% | 5-year: +135.53%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

FDC Share Price Target Chart and Table From 2024, 2025, 2026 to 2039

Year Target 1 Target 1 YoY Chg % Target 2
Current Price ₹491.50
2024 ₹579.08 +17.82% ₹587.77
2025 ₹719.39 +24.23% ₹730.18
2026 ₹900.39 +25.16% ₹913.90
2027 ₹1,095.07 +21.62% ₹1,111.50
2028 ₹1,285.31 +17.37% ₹1,304.59
2029 ₹1,392.61 +8.35% ₹1,413.50
2030 ₹1,508.35 +8.31% ₹1,530.98
2031 ₹1,710.23 +13.38% ₹1,736.34
2032 ₹1,929.85 +12.84% ₹1,958.80
2033 ₹2,135.49 +10.66% ₹2,167.52
2034 ₹2,206.14 +3.31% ₹2,239.23
2035 ₹2,297.32 +4.13% ₹2,373.10
2036 ₹2,520.08 +9.70% ₹2,585.35
2037 ₹2,764.62 +9.70% ₹2,806.09
2038 ₹2,985.67 +8.00% ₹3,030.46
2039 ₹2,950.29 -1.18% ₹3,009.86

Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.

FDC Brief Company Overview

Company Overview: FDC Limited FDC Limited, established in 1936, is a leading Indian pharmaceutical company with a global presence. Key Products and Services: FDC manufactures and markets specialized formulations in various therapeutic segments, including anti-infective,... gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, and active pharmaceutical ingredients. Its popular brands include Zifi, Ziglim Plus 2, and Electral. Diverse Product Range: The company offers a wide range of anti-oxidants, energy drinks, vitamins, and nutraceuticals under brands like Enerzal, Humyl, and Zefrich. Industry Reputation: FDC Limited has a well-established reputation in the pharmaceutical industry, known for its quality and innovation. Commitment: The company is committed to providing affordable and accessible healthcare solutions, both in India and internationally.

FDC Financial Performance

Metric Value Description
Market Capital 8,019.98 Crore Market valuation of FDC's shares.
Revenue (TTM) 2,072.31 Crore Total revenue generated by FDC over the past twelve months.
Net Income (TTM) +3,165,914,112.00 Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin +10.97% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin +15.27% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+5.70% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+3.20% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
0.87 Company's total debt divided by total shareholder equity.
Total Debt 20.12 Crore Sum of FDC's current & long-term financial obligations.
Total Cash 590.78 Crore Total amount of liquid funds available to FDC.
Beta 0.28 Beta is less than 1 indicating that the FDC's price is less volatile than the market.

Is FDC A Good Buy For Long Term?

FDC, a mid-cap stock with a market capitalization of ₹8,019.98 crore, shows promising long-term potential. Its strong revenue (₹2,072.31 crore TTM) and net profit (₹316.59 crore TTM), coupled with a healthy profit margin of 15.27%, are positive indicators. While Q2 2024-25 debt is low (₹20.12 crore) and cash reserves are substantial (₹590.78 crore), the recent 3-month return of -4.69% warrants caution. However, impressive 5-year returns (182.10%) and positive YTD returns (22.46%) suggest it's a good buy for the long term, despite short-term market fluctuations.

Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.

All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.